Robert N. Barker
Aberdeen, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
TGFβ2 Induces the Soluble Isoform of CTLA-4 - Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma.
Journal: Frontiers in immunology
Published: August 24, 2021
Low-Dose Vitamin D3 Supplementation Does Not Affect Natural Regulatory T Cell Population but Attenuates Seasonal Changes in T Cell-Produced IFN-γ: Results From the D-SIRe2 Randomized Controlled Trial.
Journal: Frontiers in immunology
Published: October 29, 2020
The red blood cell as a novel regulator of human B-cell activation.
Journal: Immunology
Published: May 19, 2020
The Soluble Isoform of CTLA-4 Correlates with Interferon-α Activity in Systemic Lupus Erythematosus.
The Soluble Isoform of CTLA-4 Correlates with Interferon-α Activity in Systemic Lupus Erythematosus.
Journal: The Journal of rheumatology
Published: December 03, 2019
Red blood cell mannoses as phagocytic ligands mediating both sickle cell anaemia and malaria resistance.
Journal: Nature communications
Published: February 18, 2019
Physiological strength electric fields modulate human T cell activation and polarisation.
Journal: Scientific reports
Published: January 18, 2019
Similarities and differences in surface receptor expression by THP-1 monocytes and differentiated macrophages polarized using seven different conditioning regimens.
Journal: Cellular immunology
Published: April 06, 2018
Differential effects of phototherapy, adalimumab and betamethasone-calcipotriol on effector and regulatory T cells in psoriasis.
Journal: The British journal of dermatology
Published: December 14, 2017
Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the major human platelet autoantigen glycoprotein IIb/IIIa in HLA-transgenic mice.
Journal: Haematologica
Published: September 04, 2017
Effective antigen presentation to helper T cells by human eosinophils.
Journal: Immunology
Published: April 18, 2016
Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus.
Journal: Arthritis research & therapy
Published: February 01, 2016
Last Updated: 09/26/2026